Browsing Tag
APP13007
2 posts
Cipla secures exclusive rights to market Formosa Pharmaceuticals’ APP13007 across 11 countries
Cipla Limited has expanded its presence in the ophthalmology market through a multi-regional licensing agreement with Formosa Pharmaceuticals,…
Formosa Pharmaceuticals, Cristália forge licensing deal for APP13007 in Brazil
Formosa Pharmaceuticals, a leading Taiwan-based pharmaceutical company, has announced a landmark licensing agreement with Cristália Produtos Químicos Farmacêuticos…